A REVIEW OF STIMULANT DRUG RESEARCH WITH HYPERACTIVE CHILDREN

Journal of Child Psychology and Psychiatry

Volumn 18, Issue 2, 1977, Pages 137-165

  Barkley, Russell A ^a  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

hyperactivity; hyperkinesis; stimulant drugs

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; MAGNESIUM HYDROXIDE; METHYLPHENIDATE; PEMOLINE;

BODY HEIGHT; BODY WEIGHT; BRAIN DAMAGED CHILD; BRAIN INJURY; CHILD; DRUG THERAPY; HYPERACTIVE CHILD; HYPERACTIVITY; REVIEW; THERAPY;

EID: 0017641942     PISSN: 00219630     EISSN: 14697610     Source Type: Journal    
DOI: 10.1111/j.1469-7610.1977.tb00425.x     Document Type: Article

References (159)

1. Effect of thioridazine, amphetamine, and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children
2. The state‐dependent effects of methylphenidate and dextro‐amphetamine
3. Measurement of attention distractibility in LD children
4. Levo‐ amphetamine vs. dextroamphetamine in minimal brain dysfunction
5. Levoamphetamine and dextro‐amphetamine: differential effect on aggression and hyperkinesis in children and dogs
6. Levoamphetamine and dextro‐amphetamine: comparative efficacy in the hyperkinetic syndrome
7. Tests for the evaluation of early childhood education
8. Predicting the response of hyperkinetic children to stimulant drugs: a review. J
9. Reduction of children's locomotor activity by modeling and the promise of contingent reward
10. A comparison of objective measures of activity and distractibility in hyperactive and nonhyperactive children
11. The effectiveness of methylphenidate hydrochloride (Ritalin) on learning and behavior in public school educable mentally retarded children
12. The behavior of children receiving benzedrine
13. Benzedrine and dezedrine in the treatment of children's behavior disorders
14. School performance of children receiving amphetamine (benzedrine) sulfate
15. Amphetamine (benzedrine) therapy of children's behavior disorders
16. Psychometric performance of children receiving amphetamine (benzedrine) sulfate
17. Average evoked responses in normal and minimally bruin dysfunctioned children treated with amphetamine: a preliminary report
18. Effects of amphetamine therapy mi hyperkinetic children
19. The effect of methylphenidate on sensory perception and integration in hyperactive children
20. The effects of methylphenidate on sensory perception in varying degrees of hyperkinetic behavior
21. Cognitive styles in hyperactive children and the effect of methylphenidate
22. Measuring effects of psychoactive medication in a child with a learning disability
23. Effects of combining methylphenidate and a classroom token system in modifying hyperactive behavior
24. Reduction of hyperactive behavior by conditioning procedures alone and combined with methylphenidate
25. The effect of drugs on hyperactivity in children with some observations of changes in mineral metabolism
26. The effect of methylphenidate on attentive behavior and autonomic arousal in hyperactive children
27. Cerebral stimulants for children with learning disorders
28. The effects of dexedrine on rapid discrimination and motor Control of hyperkinetic children under mild stress
29. A teacher rating scale for use with drug studies with children
30. The use of stimulant drugs in enhancing performance and learning
31. The effect of stimulant drugs on human figure drawings in children with minimal brain dysfunction
32. Psychological effects of stimulant drugs in children with minimal brain dysfunction
33. Pharmacotherapy of psychopathology in children
34. The effects of methylphenidate on the symptomatology and learning in disturbed children
35. Effects of methylphenidate (Ritalin) on paired‐associate learning and Porteus Maze performance in emotionally disturbed children
36. Effect of dextroamphetamine on children
37. Drugs and learning in children
38. Dextroamphetamine sulfate in children with learning disorders
39. Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction
40. Anticipating the response to amphetamine therapy in die treatment of hyperkinetic children
41. Effects of amphetamine therapy and prescriptive tutoring on the behavior and achievement of lower class hyperactive children
42. The effect of methylphenidate on the verbal productivity of children with cerebral dysfunction. J
43. Effects of benzedrine sulfate and phenobarbital on behavior problem children with abnormal electroencephalograms
44. An objective instrument for assessing hyperactivity in children
45. Effects of dextroamphetamine on hyperkinetic children: a controlled double‐blind study
46. Stop, look, and listen: the problem of sustained attention and impulse control in hyperactive and normal children. Can
47. Are drugs enough?‐To treat or to train the hyperactive child
48. The management of the hyperkinetic child
49. Methylphenidate and the activity of hyperactive children in the informal setting
50. Correlation of dextroamphetamine excretion and drug response in hyperkinetic children
51. The “one child, one drug” myth of stimulants in hyperkinesis
52. Stimulant drug treatment of hyperactive children
53. The use of dextroamphetamine with hyperkinetic children
54. Drug effects on learning in children: a selective review of I he past thirty years
55. Methylphenidate and caffeine in the treatment of children with minimal brain dysfunction
56. Depressed 5‐hydroxyindole levels associated with hyperactuive and aggressive behavior
57. Effects of dextroamphetamine, chlorpromazine, and hydroxyzine on the behavior and performance of hyperactive children
58. Amphetamines in the treatment of hyperkinetic children
59. The effect of methylphenidate on behavior of three school children: a pilot investigation
60. Children with learning problems: academic history, academic prediction, and adjustment 3 years after assessment
61. 8–10 year follow‐up of 84 children treated for behavioral disorder to rural Vermont
62. Caffeine versus methylphenidate and d‐amphetamine in minimal brain dysfunction
63. Response to methylphenidate in low socioeconomic hyperactive children
64. Hyperactivity and the machine: the actometer
65. Information processing in the child: significance of analytic and reflective attitude
66. The effects of methylphenidate on the motor skills and behavior of children with learning problems
67. Psychopharmacology for the hyperkinetic child‐dynamic considerations
68. Predicting amphetamine response in hyperkinetic children by electronic pupilography
69. Drugs and the immature organism
70. Type and prevalence of medication used in treating hyperactive children
71. Reaction time performance in behaviorally deviant children: effects of prior preparatory interval and reinforcement
72. Hyperactive children and the efficacy of psychoactive drugs as a treatment intervention
73. Hyperkinetic impulse disorder in children's behavior problems
74. Post‐encephalitic behavior disorder‐a forgotten entity. A report of 100 cases
75. The effect of drugs on behavior and the electroencephalogram of children with behavior disorders
76. Parental management, self‐concept, and drug response in minimal brain dysfunction
77. Using cerebral stimulants to treat minimal brain dysfunction
78. Methylphenidate hallucinosis
79. Diagnosis and treatment of behavior disorders in children. As cited in Knobel, M., Wolman, M, and Mason, E. Hyperkinesis and organicity in children
80. Methylphenidate for adolescents with minimal brain dysfunction
81. Studies in activity level‐VII. Effects of amphetamine drug administration on the activity level of retarded children
82. Hyperactive children as teenagers; a follow‐up study
83. Drugs in the management of minimal brain dysfunction
84. Hyperkinetic behavior and learning disorders
85. Studies in hyperkinetic behavior
86. Treatment of “minimal brain dysfunction” syndromes
87. A 5 yr follow‐up study of 91 hyperactive school children
88. The effect of benzedrine sulfate on the intelligence scores of children
89. Effect of amphetamines in hyperkinetic children: stimulant or sedative
90. Psychosis in a child associated wilh amphetamine administration
91. The influence of methylphenidate on heart rate and behavioral measures of attention in hyperactive children
92. One‐year follow‐up of hyperactive boys treated with imipramine and methylphenidate
93. Urinary noradrenaline and playroom behavior in hyperactive boys
94. Playroom observations of hyperactive children on medication
95. Imipramine and methylphenidate treatments of hyperactive boys
96. Minor physical anomalies and plasma dopamine‐beta‐hydroxylase activity in hyperactive boys
97. A 2–yr follow‐up of 72 hyperactive boy
98. Effects of methylphenidate on underachieving children
99. Effects of Ritalin on underachieving children: a replication
100. Development of activity level in children. Dev
101. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children
102. Stimulant drug treatment of hyperactive adolescents
103. Depression of growth in hyperactive children on stimulant drugs
104. The relationship between psychopathology and evoked responses before, during and after psychotropic drug treatment
105. Physiological studies of the hyperkinetic child‐I
106. Response to stimulant drug treatment in hyperactive children: prediction from ERG and neurological findings
107. Electrodermal correlates of hyperactivity in children
108. EEG aspects in the diagnosis and treatment of minimal brain dysfunction
109. Observations on effects of a central stimulant drug (methylphenidate) in children with hyperactive behavior
110. Hyperactivity in preschoolers and the effect of methylphenidate
111. Caffeine as a substitute for schedule II stimulants in hyperkinetic children
112. The effect of methylphenidate hypochloride on children with minimal brain dysfunction syndrome and subsequent hyperkinetic syndrome. Psychiat
113. Methylphenidate in children with minimal brain dysfunction: effects on attention span, visual‐motor skills and behavior
114. Controlled observations on patterns of activity, attention, and impulsivity in brain‐damaged and psychiatrically disturbed boys. Psychol
115. Alpha rhythms in the hyperkinetic child
116. Hyperactive children; a continuous long‐term placebo‐controlled follow‐up
117. Drug therapy: initiation and follow‐up
118. Methylphenidate and thioridazine: learning, reaction time, activity, and classroom behavior in disturbed children
119. Effects of psychopharmacological agents on learning disabilities
120. Methodology of psychopharmacological studies with the retarded
121. Reaction time and the effects of Ritalin on children with learning problems
122. Electrodermal activity in hyperactive boys who are methylphenidate responders
123. Anticipatory heart rate deceleration and reaction time in children with and without referral for learning disability
124. Sequential withdrawal of stimulant drugs and use of behavior therapy with two hyperactive boys
125. Dextroamphetamine responsive behavior disorder in school children
126. The effect of methylphenidate (Ritalin) on sustained attention in hyperactive children
127. Attention in hyperactive children and the effect of methylphenidate (Ritalin). J
128. Use of CNS stimulant medication in averaged electro‐encephalic audiometry with children with MBD
129. Effect of long‐term treatment of hyperactive children with methylphenidate
130. Comparison of the effects of chlorpromazine, dextroamphetamine, and methylphenidate on the behaviour and intellectual functioning of hyperactive children
131. Studies on the hyperactive child‐V. The effects of dextroamphetamine and chlorpromazine on behavior and intellectual functioning
132. Developmental hyperactivity
133. Some clinical and laboratory studies of psycho tropic drugs in children: an overview
134. Methylphenidate and haloperidol in children. Effects on attention, memory, and activity
135. Methylphenidate in children: effect of dosage
136. Effects of imipramine and dextroamphetamine on behavior of neuropsychiatrically impaired children
137. Dextroamphetamine and methyl‐phenidate in the treatment of hyperactive/aggressive children
138. Minimal brain dysfunction, stimulant drugs, and autonomic nervous system activity
139. Action of methylphenidate (Ritalin) and reserpine in behavior disorders of children and adults
140. A comparison of chlordiazepoxide, d‐amphetamine, arid placebo in the treatment of the hyperkinetic syndrome in children
141. An evaluation of methodology used in the study of psychoactive drugs for children